Back to search results

Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases

IsraelRecruitingPHASE2

Conditions

Advanced Glioblastoma · Metastatic Melanoma in the Central Nervous System · MGMT-Unmethylated Glioblastoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads

  • Ronnie Shapira Frommer, Dr

    Principal Investigator

    Ronnie Shapira, MD Study Principal Investigator Ronnie.Shapira@sheba.health.gov.il

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)